Our results suggest a limited potential for cell movement post-treatment with the aforementioned anti-tumor agents in both breast cancer cells, and this hypothesis was enhanced by elevated mean fluorescence intensity and, therefore, overexpression of vinculin in post-treated cells. The gene discussed is VCL; the disease is neoplasm.